Wave Life Sciences Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 22.11 million compared to USD 0.375 million a year ago. Net loss was USD 21.1 million compared to USD 41.3 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.62 a year ago.
For the six months, sales was USD 35.04 million compared to USD 2.13 million a year ago. Net loss was USD 48.51 million compared to USD 79.11 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 1.25 a year ago.